Citation Impact
Citing Papers
Adverse metabolic and cardiovascular consequences of circadian misalignment
2009 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
2013 StandoutNobel
Assays of different aspects of haemostasis – what do they measure?
2015 StandoutNobel
The clinically relevant CYP2C8*3 and CYP2C9*2 haplotype is inherited from Neandertals
2022 StandoutNobel
Shift work, risk factors and cardiovascular disease
1999
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
2010 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients
2009
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
2010 Standout
Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study
2005
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
A challenging system: Free energy prediction for factor Xa
2011
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Is there a hypercoagulable phase during initiation of antithrombotic therapy with oral anticoagulants in patients with atrial fibrillation?
2003
Perioperative Management of Antithrombotic Therapy
2012 Standout
Oral Anticoagulant Therapy
2012 Standout
Guidelines on the investigation and management of antiphospholipid syndrome
2012
Antithrombotic Therapy for VTE Disease
2016 Standout
Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients
1992
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Carbamazepine for acute and chronic pain in adults
2005
HLA-B*5701 Screening for Hypersensitivity to Abacavir
2008 Standout
Coordinated Transcription of Key Pathways in the Mouse by the Circadian Clock
2002 Standout
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
1995 Standout
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Shift work and vascular events: systematic review and meta-analysis
2012 Standout
Genetic and clinical factors relating to warfarin dosing
2009
Shift work and cardiovascular disease – pathways from circadian stress to morbidity
2010
The Antiphospholipid Syndrome
2002 Standout
Prevention of Venous Thromboembolism
2004 Standout
Circadian Variation of Fibrinolytic Activity in Blood
1991
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities
2015 Standout
Very Small Cerebellar Infarcts: Integration of Recent Insights into a Functional Topographic Classification
2013 Standout
The Overall Hemostasis Potential: A Laboratory Tool for the Investigation of Global Hemostasis
2010
Hormones and pregnancy: thromboembolic risks for women
2004
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Thrombogenic alleles, Escherichia coli O157:H7 infections, and hemolytic uremic syndrome
2001
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Pregnancy and Stroke
2005
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Infective endocarditis
2004 Standout
Coagulation and Fibrinolysis during Laparoscopic Cholecystectomy
1999
Mining electronic health records: towards better research applications and clinical care
2012 Standout
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Health disorders of shift workers
2003
Genetic Determinants of Response to Warfarin during Initial Anticoagulation
2008
The pharmacogenetics of antiretroviral therapy
2006
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy
2010 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Carbamazepine for chronic neuropathic pain and fibromyalgia in adults
2014
Whipple's Disease and “Tropheryma whippelii”
2001
Hyperhomocysteinemia and Venous Thrombosis
2007
Multiplex Assay for Comprehensive Genotyping of Genes Involved in Drug Metabolism, Excretion, and Transport
2007
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature
2003
Guidelines for the Primary Prevention of Stroke
2014 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2010 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association
2016
Migraine, headache, and the risk of stroke in women
2005
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
2009
Pharmacogenomics of CYP2C9: Functional and Clinical Considerations
2017
Comprehensive Assessment of Metabolic Enzyme and Transporter Genes Using the Affymetrix ® Targeted Genotyping System
2007
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
CYP2C9*8 is Prevalent Among African–Americans: Implications for Pharmacogenetic Dosing
2009
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
The Halogen Bond
2016 Standout
Homocysteine and Cardiovascular Disease
1998 Standout
Design, Structure−Activity Relationships, X-ray Crystal Structure, and Energetic Contributions of a Critical P1 Pharmacophore: 3-Chloroindole-7-yl-Based Factor Xa Inhibitors
2008
Works of Polona Peternel being referenced
Classic risk factors, hypercoagulability and migraine in young women with cerebral lacunar infarctions
2002
Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance dose
2005
Intensity of Long-Term Treatment with Warfarin Is Influenced by Seasonal Variations
2002
Poor fibrinolytic response to venous occlusion by different criteria in patients with deep vein thrombosis
1991
Markers of hemostatic system activation during treatment of deep vein thrombosis with subcutaneous unfractionated or low-molecular weight heparin
2002
Patent foramen ovale as a potential cause of paradoxical embolism in the postpartum period
1999
Factor V Leiden, prothrombin 20210G → A, methylenetetrahydrofolate reductase 677C → T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism
2003
Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis
1991
Evidence of hypercoagulability and inflammation in young patients long after acute cerebral ischaemia
2006
The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose
2006
14 Reduced diurnal rhythm of fibrinolytic activity in patients with pace-maker
1988
The influence of sequence variations in factor VII, γ-glutamyl carboxylase and vitamin K epoxide reductase complex genes on warfarin dose requirement
2006
Shift work and circadian rhythm of blood fibrinolytic parameters
1990
The 4G/5G Sequence Polymorphism in the Promoter of Plasminogen Activator Inhibitor-1 (PAI-1) Gene: Relationship to Plasma PAI-1 Level in Venous Thromboembolism
1998
A novel sequence variant in exon 7 of CYP2C9 gene (CYP2C9*24) ina patient on warfarin therapy
2006